Biotest Aktiengesellschaft (ETR:BIO3)

ETR:BIO3 Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,436	1,349	1,456	1,520	1,609	1,126
Market Cap Growth	-7.34%	-7.34%	-4.17%	-5.54%	42.88%	43.33%
Enterprise Value	1,989	1,939	2,087	2,013	2,034	1,521
Last Close Price	30.20	27.00	30.91	33.90	38.45	27.95
PE Ratio	45.76	51.11	11.47	-	-	-
Forward PE	20.10	24.51	-	-	-	-
PS Ratio	1.98	1.86	2.13	2.94	3.12	2.33
PB Ratio	2.71	2.54	2.92	4.10	4.23	2.55
P/TBV Ratio	2.75	2.58	2.97	4.20	4.35	2.62
P/FCF Ratio	44.61	41.91	-	-	103.11	-
P/OCF Ratio	23.59	22.16	-	-	47.59	-
EV/Sales Ratio	2.74	2.67	3.05	3.90	3.95	3.14
EV/EBITDA Ratio	16.18	16.06	14.19	193.51	-	87.93
EV/EBIT Ratio	24.14	22.33	17.88	-	-	-
EV/FCF Ratio	61.76	60.21	-	-	130.42	-
Debt / Equity Ratio	1.27	1.27	1.38	1.74	1.40	1.11
Debt / EBITDA Ratio	5.28	5.28	4.52	41.29	-	22.09
Debt / FCF Ratio	20.86	20.86	-	-	34.05	-
Asset Turnover	0.51	0.51	0.52	0.45	0.46	0.43
Inventory Turnover	1.12	1.12	1.13	1.45	1.63	1.24
Quick Ratio	2.04	2.04	0.84	2.37	2.52	2.49
Current Ratio	5.06	5.06	1.96	4.76	4.91	5.27
Return on Equity (ROE)	5.13%	5.13%	29.20%	-8.44%	-15.43%	-6.84%
Return on Assets (ROA)	3.81%	3.81%	5.58%	-1.09%	-2.85%	-0.42%
Return on Capital (ROIC)	4.54%	4.54%	6.62%	-1.31%	-3.45%	-0.52%
Return on Capital Employed (ROCE)	6.80%	6.80%	11.40%	-	-	-
Earnings Yield	183.79%	1.96%	8.72%	-2.09%	-3.94%	-2.79%
FCF Yield	224.16%	2.39%	-2.48%	-4.59%	0.97%	-3.88%
Dividend Yield	13.24%	0.15%	0.13%	-	0.10%	0.14%
Payout Ratio	606.06%	6.06%	-	-	-	-
Total Shareholder Return	13.24%	0.15%	0.13%	-	0.10%	0.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.